Yingzhuo Xu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Cell death & disease

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoshu Zhou, Rui Zhou, Xinrui Rao, Jiaxin Hong, Qianwen Li, Xiaohua Jie, Jian Wang, Yingzhuo Xu, Kuikui Zhu, Zhenyu Li, Gang Wu
Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer. Cell death & disease 13 (7) (2022)
Yingzhuo Xu, Jian Wang, Xu Wang, Xiaoshu Zhou, Jing Tang, Xiaohua Jie, Xijie Yang, Xinrui Rao, Yunhong Xu, Biyuan Xing, Zhenyu Li, Gang Wu
Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors. Cell death discovery 8 (1) (2022)
Xinrui Rao, Xiaoshu Zhou, Geng Wang, Xiaohua Jie, Biyuan Xing, Yingzhuo Xu, Yunshang Chen, Jun Li, Kuikui Zhu, Zilong Wu, Gang Wu, Chuangyan Wu, Rui Zhou
NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell death & disease 13 (10) (2022)
Yunshang Chen, Xiaohua Jie, Biyuan Xing, Zilong Wu, Xijie Yang, Xinrui Rao, Yingzhuo Xu, Dong Zhou, Xiaorong Dong, Tao Zhang, Kunyu Yang, Zhenyu Li, Gang Wu
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis. Cell death & disease 13 (2) (2022)